Combination therapy with ruxolitinib plus 5‐azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast‐phase myeloproliferative neoplasms

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2014-12, Vol.167 (5), p.714-716
Hauptverfasser:	Mwirigi, Anne, Galli, Sofia, Keohane, Clodagh, Raj, Kavita, Radia, Deepti H., Harrison, Claire N., McLornan, Donal P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Azacitidine - administration & dosage Blast Crisis - drug therapy blast phase Female Hematologic Neoplasms - drug therapy Humans hypomethylating agents Janus Kinase inhibitors Male Myeloproliferative Disorders - drug therapy myeloproliferative neoplasms Pyrazoles - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!